Brand Reference: Minocin, Solodyn
| Metric | Verified Benchmark | Source |
|---|---|---|
| Minocycline Hydrochloride RxNorm Concept ID | 6980 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.2400 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $78.00 / mo | CMS NADAC + U.S. Retail Markup Index |
| Mark Cuban Cost Plus Wholesale Price | $10.60 / mo | Cost Plus Drugs Wholesale Feed |
| Community Mean Out-of-Pocket Paid | $13.50 / mo | 16 Zero-PHI Verified Patient Logs |
Highly lipophilic 7-dimethylamino tetracycline that achieves high lipid-rich pilosebaceous concentrations, suppressing C. acnes lipase production, neutrophil chemotaxis, and microglial/dermal reactive oxygen radicals.
For self-pay patients filling Minocycline Hydrochloride (NDC 00378-0605-01), direct wholesale and telehealth fulfillment drops monthly spend from $78.00 retail to $10.60 (86% savings against a $0.2400 CMS pharmacy acquisition baseline).
Clinical clearance of Minocycline Hydrochloride (Lipophilic Sebum-Concentrating Tetracycline Derivative) relies on hepatic n-demethylation; hepatobiliary and renal clearance with a 11–22 hours half-life; patients absorbing at 95%–100% oral (minimally affected by food) bioavailability typically observe target onset around 3–6 weeks deep inflammatory nodule calming.
FDA clinical labeling for Minocycline Hydrochloride restricts administration in drug-induced lupus or autoimmune hepatitis history; pregnancy; concomitant isotretinoin across 1 mg/kg ER PO once daily (Solodyn), 50 mg PO BID, 100 mg PO BID (short-course), with self-reported patient tracking dominated by vestibular vertigo/dizziness (18% of reports), blue-gray scar hyperpigmentation (prolonged use) (7% of reports).
Across 16 verified cash-pay logs, Minocycline Hydrochloride achieves a 77.90% Worth-It rating with out-of-pocket spend averaging $13.50/mo versus $78.00/mo walk-in retail.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Switched to Cost Plus Drugs at 1 mg/kg ER PO once daily (Solodyn) for Minocycline Hydrochloride; monthly out-of-pocket dropped to $9.33 compared with $78.00 retail.
Completed 10 weeks on Minocycline Hydrochloride (50 mg PO BID). Zero notable side effects on steady dosing.
Consistent biomarker response on 100 mg PO BID (short-course) Minocycline Hydrochloride sourced via TeleMed ($12.30/mo cash pay without insurance prior authorization).